Eyenovia Overview

Founded 2014
Status Public
Employees 29
Stock Symbol EYEN
Stock Symbol
Share Price $2.89 (As of Friday Closing)

Eyenovia General Information


Eyenovia Inc is a clinical-stage biopharmaceutical company operating in the US. It is engaged in developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to deliver micro-therapeutics for the treatment of prominent eye diseases, such as glaucoma, dry eyes, allergic eye disease and many others. The pipeline products of the company are MicroProst for chronic angle closure glaucoma, MicroStat for pharmacologic mydriasis, MicroTears for dry eye and MicroPine for myopia.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Stock Exchange
Primary Office
  • 295 Madison Avenue
  • Suite 2400
  • New York, NY 10017
  • United States
+1 (917) 000-0000

Eyenovia Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Eyenovia Stock Performance

(As of Tuesday closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.89 $2.89 $1.11 - $5.50 $57.2M 19.8M 53.5K -$1.35

Eyenovia Financials Summary

In Thousands,
TTM 31-Mar-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 31,375 58,315 11,643
Revenue 0 0 0 0
EBITDA (20,787) (21,293) (17,237) (5,107)
Net Income (20,675) (21,157) (17,253) (5,130)
Total Assets 14,909 14,698 20,015 5,643
Total Debt 443 42 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Eyenovia Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Eyenovia‘s full profile, request access.

Request a free trial

Eyenovia Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Ocular Therapeutix Formerly VC-backed Bedford, MA 000 00000 00000000000 00000
0000000000 0000000 Formerly VC-backed San Diego, CA 000 00000 000000&0
000000 00000000000 Formerly VC-backed Redwood City, CA 00 00000 00000000 00000
0000 000000000000 Angel-Backed Austin, TX 00.000 0000000000 00.000

Eyenovia Executive Team (5)

Name Title Board Seat Contact Info
Tsontcho Ianchulev MD Chief Executive Officer & Chief Medical Officer
John Gandolfo Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Earnest Mario Ph.D Director
Fred Eshelman Chairman

1 Former Executive

Eyenovia Board Members (6)

To view Eyenovia‘s full board member team, request access >>
Name Representing Role Since
Anthony Sun MD Self Board Member 000 0000
Charles Mather Self Board Member 000 0000
Curt LaBelle Eyenovia Board Member 000 0000
Fred Eshelman Self Chairman 000 0000
Kenneth Lee Jr. Self Board Member 000 0000

1 Former Board Member

Eyenovia Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Eyenovia‘s full profile, request access.

Request a free trial